Glyburide
- Product NDC
- 68071-4142
- 11-digit product format
- 680714142
- Labeler code
- 68071
- Product ID
- 68071-4142_c21527be-e32c-4f70-e053-2995a90a8630
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glyburide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmceuticals,Inc.
- Application
- ANDA206079
- Marketing category
- ANDA
- Marketing start
- 2016-06-01
- Marketing end
- 0000-00-00
- Substance
- GLYBURIDE
- Active strength
- 3 mg/1
- Pharmacologic classes
- Sulfonylurea [EPC],Sulfonylurea Compounds [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 68071-4142-3 | 2023-01-30 | C162847 | 48780-1 | ba0f9c33-0e05-a910-e053-dadaa90a0b85 | Glyburide Tablets, USP 1.25 mg, 2.5 mg and 5 mg Rx only |
| 68071-4142-6 | 2023-01-30 | C162847 | 48780-1 | ba0f9c33-0e05-a910-e053-dadaa90a0b85 | Glyburide Tablets, USP 1.25 mg, 2.5 mg and 5 mg Rx only |
| 68071-4142-9 | 2023-01-30 | C162847 | 48780-1 | ba0f9c33-0e05-a910-e053-dadaa90a0b85 | Glyburide Tablets, USP 1.25 mg, 2.5 mg and 5 mg Rx only |
| 68071-4142-3 | 2021-05-11 | C162847 | 48780-1 | ba0f9c33-0e05-a910-e053-dadaa90a0b85 | Glyburide Tablets, USP 1.25 mg, 2.5 mg and 5 mg Rx only |
| 68071-4142-6 | 2021-05-11 | C162847 | 48780-1 | ba0f9c33-0e05-a910-e053-dadaa90a0b85 | Glyburide Tablets, USP 1.25 mg, 2.5 mg and 5 mg Rx only |
| 68071-4142-9 | 2021-05-11 | C162847 | 48780-1 | ba0f9c33-0e05-a910-e053-dadaa90a0b85 | Glyburide Tablets, USP 1.25 mg, 2.5 mg and 5 mg Rx only |
| 68071-4142-3 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-0e05-a910-e053-dadaa90a0b85 | Glyburide Tablets, USP 1.25 mg, 2.5 mg and 5 mg Rx only |
| 68071-4142-6 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-0e05-a910-e053-dadaa90a0b85 | Glyburide Tablets, USP 1.25 mg, 2.5 mg and 5 mg Rx only |
| 68071-4142-9 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-0e05-a910-e053-dadaa90a0b85 | Glyburide Tablets, USP 1.25 mg, 2.5 mg and 5 mg Rx only |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68071-4142-3 | Glyburide | 30 in 1 BOTTLE | TABLET | 30 | | 2 |
| 68071-4142-6 | Glyburide | 60 in 1 BOTTLE | TABLET | 60 | | 2 |
| 68071-4142-9 | Glyburide | 90 in 1 BOTTLE | TABLET | 90 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68071-4142 | GLYBURIDE TABLET [NUCARE PHARMCEUTICALS,INC.] | 2 | Legacy NDC, 3 package rows | 20210512_5cdfba1e-7179-a2ee-e053-2991aa0adce9.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68071-4142-3 | 68071414203 | 30 TABLET in 1 BOTTLE (68071-4142-3) | 30 tablet | 2017-10-31 | 0000-00-00 | No | No | Current |
| 68071-4142-6 | 68071414206 | 60 TABLET in 1 BOTTLE (68071-4142-6) | 60 tablet | 2017-10-31 | 0000-00-00 | No | No | Current |
| 68071-4142-9 | 68071414209 | 90 TABLET in 1 BOTTLE (68071-4142-9) | 90 tablet | 2017-10-31 | 0000-00-00 | No | No | Current |